Literature DB >> 24358033

Citrobacter Infection and Wnt signaling.

Shahid Umar1.   

Abstract

Gut flora generally contributes to a healthy environment while both commensal and pathogenic bacteria that influence the innate and adaptive immune responses, can cause acute and/or chronic mucosal inflammation. Citrobacter rodentium (C. rodentium) is a member of the family of enteropathogens that provide an excellent in vivo model to investigate the host-pathogen interactions in real-time. It is the etiologic agent for transmissible murine colonic hyperplasia (TMCH) while inflammation following C. rodentium infection is dependent upon the genetic background. Ongoing and completed studies in this model have so far established that Wnt/β-catenin, Notch and PI3K pathways regulate colonic crypt hyperplasia while epithelial-stromal cross-talk, mediated by MEK/ERK/NF-κB signaling, regulates inflammation and/or colitis in susceptible strains. The C. rodentium-induced hyperplastic state also increases the susceptibility to either mutagenic insult or in mice heterozygous for Apc gene. The ability to modulate the host response to C. rodentium infection therefore provides an opportunity to delineate the mechanisms that determine mucosal hyperplasia, intestinal inflammation, and/or neoplasia as disease outcomes.

Entities:  

Keywords:  Citrobacter rodentium; Colon Cancer; Enteric Infection; Inflammation; Inflammatory Bowel Disease; Microbiota; Wnt Signaling

Year:  2012        PMID: 24358033      PMCID: PMC3865928          DOI: 10.1007/s11888-012-0143-4

Source DB:  PubMed          Journal:  Curr Colorectal Cancer Rep        ISSN: 1556-3790


  97 in total

1.  Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.

Authors:  W Liu; X Dong; M Mai; R S Seelan; K Taniguchi; K K Krishnadath; K C Halling; J M Cunningham; L A Boardman; C Qian; E Christensen; S S Schmidt; P C Roche; D I Smith; S N Thibodeau
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

Review 2.  The gut flora as a forgotten organ.

Authors:  Ann M O'Hara; Fergus Shanahan
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

Review 3.  Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa.

Authors:  Nita H Salzman; Mark A Underwood; Charles L Bevins
Journal:  Semin Immunol       Date:  2007-05-07       Impact factor: 11.130

4.  Structural studies on the O-polysaccharide of the lipopolysaccharide produced by Citrobacter rodentium (ATCC 51459).

Authors:  L L MacLean; M B Perry
Journal:  Eur J Biochem       Date:  2001-11

5.  Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.

Authors:  Tim Reichling; Kathleen Heppner Goss; Daniel J Carson; Robert W Holdcraft; Cathy Ley-Ebert; Dave Witte; Bruce J Aronow; Joanna Groden
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

6.  Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.

Authors:  V Korinek; N Barker; P J Morin; D van Wichen; R de Weger; K W Kinzler; B Vogelstein; H Clevers
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

7.  Critical roles of Notch and Wnt/β-catenin pathways in the regulation of hyperplasia and/or colitis in response to bacterial infection.

Authors:  Ishfaq Ahmed; Parthasarathy Chandrakesan; Ossama Tawfik; Lijun Xia; Shrikant Anant; Shahid Umar
Journal:  Infect Immun       Date:  2012-06-18       Impact factor: 3.441

Review 8.  Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia.

Authors:  S A Luperchio; D B Schauer
Journal:  Microbes Infect       Date:  2001-04       Impact factor: 2.700

9.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

10.  beta-Catenin stabilization imparts crypt progenitor phenotype to hyperproliferating colonic epithelia.

Authors:  Joseph H Sellin; Yu Wang; Pomila Singh; Shahid Umar
Journal:  Exp Cell Res       Date:  2008-10-29       Impact factor: 3.905

View more
  6 in total

Review 1.  Stromal contributions to the carcinogenic process.

Authors:  Mark Spaw; Shrikant Anant; Sufi Mary Thomas
Journal:  Mol Carcinog       Date:  2016-11-05       Impact factor: 4.784

Review 2.  The Microbiome in Pancreatic Cancer-Implications for Diagnosis and Precision Bacteriophage Therapy for This Low Survival Disease.

Authors:  Mwila Kabwe; Stuart Dashper; Joseph Tucci
Journal:  Front Cell Infect Microbiol       Date:  2022-05-19       Impact factor: 6.073

3.  Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and Reduces Cancer via TLR2 Signaling in a Rat Model of Colon Cancer.

Authors:  Eugene Dogkotenge Kuugbee; Xueqi Shang; Yaser Gamallat; Djibril Bamba; Annoor Awadasseid; Mohammed Ahmed Suliman; Shizhu Zang; Yufang Ma; Gift Chiwala; Yi Xin; Dong Shang
Journal:  Dig Dis Sci       Date:  2016-07-06       Impact factor: 3.199

Review 4.  The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases.

Authors:  Marcelo José Barbosa Silva; Matheus Batista Heitor Carneiro; Brunna dos Anjos Pultz; Danielle Pereira Silva; Mateus Eustáquio de Moura Lopes; Liliane Martins dos Santos
Journal:  J Immunol Res       Date:  2015-02-22       Impact factor: 4.818

5.  Role of bacterial infection in the epigenetic regulation of Wnt antagonist WIF1 by PRC2 protein EZH2.

Authors:  B C Roy; D Subramaniam; I Ahmed; V R Jala; C M Hester; K A Greiner; B Haribabu; S Anant; S Umar
Journal:  Oncogene       Date:  2014-12-08       Impact factor: 9.867

Review 6.  Microbiota and cancer: current understanding and mechanistic implications.

Authors:  A A Khan; A T Sirsat; H Singh; P Cash
Journal:  Clin Transl Oncol       Date:  2021-08-13       Impact factor: 3.405

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.